Yutaka Tokuda
- Oncology top 1%
- HER2/EGFR in Cancer Research 49
- Cancer Treatment and Pharmacology 35
- Cancer Research top 2%
- Breast Cancer Treatment Studies 45
- Cancer Genomics and Diagnostics 11
-
- Monoclonal and Polyclonal Antibodies Research 19
- Immunology top 5%
- Immunotherapy and Immune Responses 18
- Immune Cell Function and Interaction 13
-
- Breast Lesions and Carcinomas 17
- Co-authors
- Naoki NiikuraNaoki HayashiYasuhiro SuzukiTomoo TajimaNaoto T. UenoGabriel N. HortobágyiShana L. PallaShinobu Umemura
- Journals
- Journal of Clinical Oncology (11 papers)SHILAP Revista de lepidopterología (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Yutaka Tokuda
169 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 124
- Oncology 2.0k
- Cancer Research 910
- Radiology, Nuclear Medicine and Imaging 738
- Pulmonary and Respiratory Medicine 787
- Immunology 461
Countries citing papers authored by Yutaka Tokuda
This map shows the geographic impact of Yutaka Tokuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Tokuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Tokuda more than expected).
Fields of papers citing papers by Yutaka Tokuda
This network shows the impact of papers produced by Yutaka Tokuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Tokuda. The network helps show where Yutaka Tokuda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yutaka Tokuda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 17 | |
| 2 | 2017 | 20 | |
| 3 | 2017 | 7 | |
| 4 | 2017 | 0 | |
| 5 | 2015 | 131 | |
| 6 | 2015 | 63 | |
| 7 | 2014 | 37 | |
| 8 | A comparative clinical evaluation of the assay of serum extracellular domain of HER2 protein using a chemiluminescent immunoassay method in breast cancer patients with or without HER2 protein expression in immunohistochemistry. | 2012 | 3 |
| 9 | 2007 | 55 | |
| 10 | 2005 | 27 | |
| 11 | [A multicenter study to determine the efficacy and safety of strontium (89Sr) chloride for palliation of painful bony metastases in cancer patients]. | 2005 | 5 |
| 12 | 2003 | 89 | |
| 13 | 2001 | 11 | |
| 14 | 1993 | 2 | |
| 15 | 1993 | 3 | |
| 16 | 1992 | 26 | |
| 17 | 1991 | 28 | |
| 18 | 1990 | 1 | |
| 19 | [Hematopoietic recovery after autologous bone marrow transplantation in high-dose chemotherapy of cancer patients]. | 1989 | 2 |
| 20 | [The experience with the antiepilepticum "Pheneturide"]. | 1961 | 1 |
About Yutaka Tokuda
Yutaka Tokuda is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 177 papers that have together received 3.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (49 papers), Breast Cancer Treatment Studies (45 papers), Cancer Treatment and Pharmacology (35 papers), Monoclonal and Polyclonal Antibodies Research (19 papers), Immunotherapy and Immune Responses (18 papers), Breast Lesions and Carcinomas (17 papers), Immune Cell Function and Interaction (13 papers) and Cancer Genomics and Diagnostics (11 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (910 citations) and Radiology, Nuclear Medicine and Imaging (738 citations). Yutaka Tokuda has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Naoki Niikura, Naoki Hayashi, Yasuhiro Suzuki, Tomoo Tajima, Naoto T. Ueno, Gabriel N. Hortobágyi, Shana L. Palla, Shinobu Umemura, Yuki Saito and Seigo Nakamura. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.